Eval. of Sirolimus in Treatment of Bilateral Geographic Atrophy
Eval. of Sirolimus in Treatment of Bilateral Geographic Atrophy
批准号:
9155592
负责人:
EMILY Y CHEW
金额:
$14.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAge related macular degenerationAreaBilateralCellsClinical ProtocolsDrusenEyeFundus photographyImageInflammationInjection of therapeutic agentMasksMeasuresOutcomeParticipantPatientsPharmaceutical PreparationsReadingRelative (related person)RetinaSafetySirolimusTestingVisionbasedigitalgeographic atrophymaculapreventprimary outcomesecondary outcome
中文摘要
这项研究将确定一种名为西罗莫司的药物是否可以安全地用于地图状萎缩症患者,以及它是否可以帮助保护患者的视力。GA是干性年龄相关性黄斑变性(AMD)的晚期形式。AMD影响黄斑,视网膜的中心部分需要敏锐,清晰的视觉。有两种类型的AMD,湿型和干型。在干性AMD中,黄斑中的细胞死亡。GA可能至少部分由炎症引起。西罗莫司有助于预防炎症,因此可能有助于治疗GA。
英文摘要
This study will determine if a drug called sirolimus is safe to give to people with geographic atrophy GA and if it can help preserve vision in patients. GA is an advanced form of dry age-related macular degeneration (AMD). AMD affects the macula, the central part of the retina needed for sharp, clear vision. There are two types of AMD, wet and dry. In dry AMD, cells in the macula die.GA may at least partly be caused by inflammation. Sirolimus helps prevent inflammation and therefore may help treat GA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ranibizumab for Advanced Ocular Disease of VHL Disease
-
批准号:6968628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of V
-
批准号:7141780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
FIND (Familial Investigation of Nephropathy in Diabetes)
-
批准号:8737631
-
项目类别:
-
资助金额:$0.95万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study
-
批准号:7968439
-
项目类别:
-
资助金额:$3.06万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Eval. of Sirolimus in Treatment of Bilateral Geographic Atrophy
-
批准号:8938341
-
项目类别:
-
资助金额:$13.09万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:8938315
-
项目类别:
-
资助金额:$2.42万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Medical Retina Fellowship
-
批准号:9362461
-
项目类别:
-
资助金额:$19.42万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
MACTEL1
-
批准号:8339801
-
项目类别:
-
资助金额:$1.64万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:10019993
-
项目类别:
-
资助金额:$5.51万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study
-
批准号:10020007
-
项目类别:
-
资助金额:$5.51万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
AMD Ryan Initiative Study (ARIS)
-
批准号:10266915
-
项目类别:
-
资助金额:$2.92万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:10930505
-
项目类别:
-
资助金额:$3.85万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study
-
批准号:10930515
-
项目类别:
-
资助金额:$3.85万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab (16-EI-0159)
-
批准号:10930533
-
项目类别:
-
资助金额:$3.85万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
MACTEL1
-
批准号:8149210
-
项目类别:
-
资助金额:$1.56万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Anti-VEGF Pegylated Aptamer for Advanced Ocular Disease
-
批准号:7141775
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Evaluation of Age-Related Eye Disease Study (AREDS) Clin
-
批准号:7141777
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Anti-VEGF Pegylated Aptamer for Advanced Ocular Disease
-
批准号:6968625
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:8556831
-
项目类别:
-
资助金额:$2.44万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Eval. of Sirolimus in Treatment of Bilateral Geographic Atrophy
-
批准号:8737659
-
项目类别:
-
资助金额:$14.18万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
海外基金